Pandion Therapeutics
AcquiredWatertown, United States · Founded 2015 · $138.0M raised
- Headquarters
- Watertown, Massachusetts
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Total Funding
- $138.0M
- Last Round
- $80.0M Series BApr 2020
- Rounds
- 2
About
Biotech developing bispecific antibody therapeutics for localized immunomodulation in autoimmune diseases; acquired by Merck in 2021.
Summary
Pandion Therapeutics is a Biotech company based in Watertown, United States, founded in 2015. It has raised $138.0M in total across 2 rounds, most recently a $80.0M Series B round in Apr 2020. Investors include Polaris Partners, Jerel Davis and Roche Venture Fund.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Feb 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company